Novo Nordisk and Anthropic launched a partnership to accelerate medicine discovery and development. The Wegovy manufacturer will integrate Anthropic’s Claude Science AI models into its research and development workflows.
Scientists will use the technology to improve biological reasoning and streamline complex research processes. This collaboration supports Novo Nordisk’s strategic goal to transition into an AI-driven healthcare company.
The initiative aims to increase productivity and reduce the time required to bring new chronic disease treatments to market.